| Temporal transcriptional response to ethylene gas drives growth hormone cross-regulation in Arabidopsis KN Chang, S Zhong, MT Weirauch, G Hon, M Pelizzola, H Li, SC Huang, ... Elife 2, e00675, 2013 | 403 | 2013 |
| Integrated genomic DNA/RNA profiling of hematologic malignancies in the clinical setting J He, O Abdel-Wahab, MK Nahas, K Wang, RK Rampal, AM Intlekofer, ... Blood 127 (24), 3004-3014, 2016 | 284 | 2016 |
| Analytical Validation of a Hybrid Capture–Based Next-Generation Sequencing Clinical Assay for Genomic Profiling of Cell-Free Circulating Tumor DNA TA Clark, JH Chung, M Kennedy, JD Hughes, N Chennagiri, DS Lieber, ... The Journal of Molecular Diagnostics 20 (5), 686-702, 2018 | 221 | 2018 |
| DREM 2.0: Improved reconstruction of dynamic regulatory networks from time-series expression data MH Schulz, WE Devanny, A Gitter, S Zhong, J Ernst, Z Bar-Joseph BMC Systems Biology 6 (1), 104, 2012 | 144 | 2012 |
| Targeted next-generation sequencing panel (GlioSeq) provides comprehensive genetic profiling of central nervous system tumors MN Nikiforova, AI Wald, MA Melan, S Roy, S Zhong, RL Hamilton, ... Neuro-oncology 18 (3), 379-387, 2016 | 125 | 2016 |
| A phase I multicenter study to assess the safety, tolerability, and immunogenicity of mRNA-4157 alone in patients with resected solid tumors and in combination with … HA Burris, MR Patel, DC Cho, JM Clarke, M Gutierrez, TZ Zaks, ... Journal of Clinical oncology 37 (15_suppl), 2523-2523, 2019 | 114 | 2019 |
| A Multiplexed Amplicon Approach for Detecting Gene Fusions by Next-Generation Sequencing C Beadling, AI Wald, A Warrick, TL Neff, S Zhong, YE Nikiforov, ... The Journal of Molecular Diagnostics 18 (2), 165-175, 2016 | 78 | 2016 |
| Molecular characterization of sporadic pediatric thyroid carcinoma with the DNA/RNA ThyroSeq v2 next-generation sequencing assay JL Picarsic, MA Buryk, J Ozolek, S Ranganathan, SE Monaco, JP Simons, ... Pediatric and Developmental Pathology 19 (2), 115-122, 2016 | 75 | 2016 |
| THADA fusion is a mechanism of IGF2BP3 activation and IGF1R signaling in thyroid cancer F Panebianco, LM Kelly, P Liu, S Zhong, S Dacic, X Wang, AD Singhi, ... Proceedings of the National Academy of Sciences 114 (9), 2307-2312, 2017 | 71 | 2017 |
| DECOD: fast and accurate discriminative DNA motif finding P Huggins, S Zhong, I Shiff, R Beckerman, O Laptenko, C Prives, ... Bioinformatics 27 (17), 2361-2367, 2011 | 64 | 2011 |
| Biological interaction networks are conserved at the module level GE Zinman, S Zhong, Z Bar-Joseph BMC systems biology 5 (1), 134, 2011 | 53 | 2011 |
| Genomics of primary chemoresistance and remission induction failure in paediatric and adult acute myeloid leukaemia FC Brown, P Cifani, E Drill, J He, E Still, S Zhong, S Balasubramanian, ... British journal of haematology 176 (1), 86-91, 2017 | 38 | 2017 |
| Clinicopathologic features of a series of primary renal CIC-rearranged sarcomas with comprehensive molecular analysis S Mangray, DR Kelly, S LeGuellec, E Fridman, S Aggarwal, M Shago, ... The American journal of surgical pathology 42 (10), 1360-1369, 2018 | 34 | 2018 |
| Predicting tissue specific transcription factor binding sites S Zhong, X He, Z Bar-Joseph BMC Genomics 14 (1), 796, 2013 | 33 | 2013 |
| Kinase domain activation through gene rearrangement in multiple myeloma GJ Morgan, J He, R Tytarenko, P Patel, OW Stephens, S Zhong, ... Leukemia 32 (11), 2435-2444, 2018 | 31 | 2018 |
| Distinct age-associated molecular profiles in acute myeloid leukemia defined by comprehensive clinical genomic profiling K Tarlock, S Zhong, Y He, R Ries, E Severson, M Bailey, S Morley, ... Oncotarget 9 (41), 26417, 2018 | 28 | 2018 |
| Primary Spinal Epidural CIC-DUX4 Undifferentiated Sarcoma in a Child JE Donahue, E Yakirevich, S Zhong, DO Treaba, NS Lakis, SM Ali, ... Pediatric and Developmental Pathology 21 (4), 411-417, 2018 | 22 | 2018 |
| Personalized cancer vaccine epitope selection S Zhong, B Breton, I McFadyen, K Hopson, V Luczkow, M Garnaas US Patent App. 17/255,949, 2021 | 21 | 2021 |
| 102PAnalytic validation of a next generation sequencing assay to identify tumor mutational burden from blood (bTMB) to support investigation of an anti-PD-L1 agent … D Fabrizio, C Malboeuf, D Lieber, S Zhong, J He, E White, M Coyne, ... Annals of Oncology 28 (suppl_5), 2017 | 21 | 2017 |
| Biomarker correlates with response to NY-ESO-1 TCR T cells in patients with synovial sarcoma A Gyurdieva, S Zajic, YF Chang, EA Houseman, S Zhong, J Kim, ... Nature Communications 13 (1), 1-18, 2022 | 17 | 2022 |
